The National Institute of General Medical Sciences (NIGMS) awarded a $166,204 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Medical College of Wisconsin, Inc. to develop and advance cell-free DNA as a novel biomarker with predictive and prognostic roles in sepsis. The primary research goal is to use machine learning methods to identify septic patients at risk of complications and test those hypotheses in silico, in vitro, and in vivo. This award will provide the necessary resources and skills for the principal investigator, Dr. Semenkovich, to become a successful independent investigator in this area. The grant period runs from August 1, 2024 to July 31, 2028.
Generated 1/28/25, 7:44 AM